<p><strong>Asthma</strong>: This fixed-dose combination of Fluticasone Propionate and Formoterol Fumarate is indicated in the regular treatment of asthma where the use of a combination product (an inhaled corticosteroid and a long-acting &szlig;2 agonist) is appropriate:</p>

<ul>
	<li>For patients not adequately controlled with inhaled corticosteroids and &quot;as required&quot; inhaled short-acting &szlig;2 agonist. Or,</li>
	<li>For patients already adequately controlled on both an inhaled corticosteroid and a long-acting &szlig;2 agonist.</li>
</ul>

<p>Fluticasone Propionate 125 mcg and Formoterol Fumarate 5 mcg inhaler are indicated in adults and adolescents aged 12 years and above.<br />
<br />
<strong>COPD</strong>: Fluticasone Propionate and Formoterol Fumarate is recommended when a long-acting &szlig;2 agonist/Inhaled corticosteroid is indicated &amp; patients are unable to use other long-acting &szlig;2 agonist/Inhaled corticosteroid.<br />
<br />
Fluticasone Propionate 125 mcg and Formoterol Fumarate 5 mcg inhaler is indicated in adults only.</p>